Validation of new items for diagnosing primary hyperhidrosis, and estimation of the prevalence of primary hyperhidrosis
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf013 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Mattias A S Henning und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Zealand University Hospital, Sygehusvej 5, 4000 Roskilde, Denmark. Hauptthemen laut MEDLINE: Hyperhidrosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: LEO Foundation.
Abstract (Originalsprache)
Background
The Multi-Specialty Working Group on the Recognition, Diagnosis, and Treatment of Primary Focal Hyperhidrosis has developed evidence-based consensus criteria for diagnosing primary hyperhidrosis (PHH).
Objectives
To validate new questionnaire items for self-reported classification of PHH based on the consensus criteria and to estimate the prevalence of PHH.
Methods
This was a cross-sectional diagnostic accuracy study. Questionnaires containing the index tests and reference tests were distributed to blood donors at blood banks between June and December 2021 in Region Zealand, Denmark. The index tests were the two questions ‘Have you had troublesome sweating?’ and ‘Have you ever had troublesome sweating?’, which were used to create six single-item algorithms for classifying PHH. The reference test comprised the consensus criteria.
Results
Overall, 1071 (95.9%) of 1083 eligible blood donors completed the index tests. The reference test classified 59 participants as having PHH and 980 as not having PHH, generating a prevalence of 5.7% [95% confidence interval (CI) 4.4–7.3]. The algorithms with the highest combined sensitivity and specificity were algorithm 2 with a sensitivity of 0.94 (95% CI 0.77–0.99) and specificity of 0.94 (95% CI 0.92–0.95), and algorithm 5 with a sensitivity of 0.94 (95% CI 0.80–0.99) and specificity of 0.92 (95% CI 0.90–0.94).
Conclusions
With high diagnostic accuracy, these items allow for the identification of individuals with and without PHH, which may prove useful in epidemiological research. Validation in the general population is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Zealand University Hospital, Sygehusvej 5, 4000 Roskilde, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Department of Clinical Immunology, Zealand University Hospital, Køge, Denmark.
- Næstved Sygehus, Næstved, Denmark.
ORCID-Profile: Mattias A S Henning
Förderung
- LEO Foundation
Zitieren
APA
Henning, M. A. S., Al-Rahimi, H. I., Ibler, K. S., Jemec, G. B. E., & Pedersen, O. B. (2025). Validation of new items for diagnosing primary hyperhidrosis, and estimation of the prevalence of primary hyperhidrosis. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf013
Vancouver
Henning MAS, Al-Rahimi HI, Ibler KS, Jemec GBE, Pedersen OB. Validation of new items for diagnosing primary hyperhidrosis, and estimation of the prevalence of primary hyperhidrosis. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf013
BibTeX
@article{Henning2025,
author = {Henning, Mattias A S and Al-Rahimi, Hajer I and Ibler, Kristina S and Jemec, Gregor B E and Pedersen, Ole B},
title = {Validation of new items for diagnosing primary hyperhidrosis, and estimation of the prevalence of primary hyperhidrosis},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf013}
}
EUVIMED